홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NUVB
#3994
Nuvation Bio Inc.
5.9
2
+5.71%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+5.71%
월간 변동
+5.53%
6달 변화
+98.66%
년간 변동율
+203.59%
이전 종가
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
양
1 640
마켓
주식
헬스케어
NUVB
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
216.65 M
218.06 M
217.8 M
218.05 M
337.68 M
—
Valuation ratios
Enterprise value
—
18.62 T
4.44 T
645.16 M
1.77 B
4.12 B
Price to earnings ratio
—
—
-4.21
-4.49
-1.26
-13.64
Price to sales ratio
—
—
-0.37
-2.66
0.09
0.22
Price to cash flow ratio
—
—
0
0.01
0.01
0.02
Price to book ratio
—
—
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
-0.11
-0.16
-0.12
-1.05
-0.38
Return on equity %
—
-0.12
-0.16
-0.13
-1.22
-0.56
Return on invested capital %
—
-502.05
-8 731.74
-6 118.89
-11.72 K
-2 524.3
Gross margin %
—
100
100
100
10.1
179.45
Operating margin %
—
-54.25 K
10.16 K
77.38 K
-7 527.33
-4 603.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
-50.49 K
8 845.42
58.76 K
-7 213.76
-4 238.15
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
0.46
45.62
50.7
44.11
9.04
35.92
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
-0
-0
0.01
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-443.46
-310.67
-485.22
-595.27
EBIT per share
—
—
—
—
-2 204.94
-727.84
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3 050.07
2 792.46
1 870.33
6 634.85
Net current asset value per share
—
—
3 079.16
2 816.31
1 958
6 892.76
Tangible book value per share
—
—
3 022.67
2 764.63
1 708.38
4 918.68
Working capital per share
—
—
3 018.43
2 752.47
1 741.29
6 124.83
Book value per share
—
—
3 022.67
2 764.63
1 725.58
5 018.94
뉴스
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
누베이션 바이오, Ibtrozi 판매 호조에 B.Riley ’매수’ 유지
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
누베이션 바이오, Truist Securities 목표 주가 13달러로 상향
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
누베이션 바이오 목표 주가 17달러로 하향 조정
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright